-
Christina Jewett
Posts
FDA Panel Recommends Pulling Preterm Birth Drug From the Market
The agency has weighed years of study that showed the treatment given accelerated approval 11 years ago was not effective.
F.D.A. Confirms Widespread Shortages of Adderall
The agency cited Teva’s continuing supply problems as well as those of other drug makers struggling to fill the gap.